HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Growth retardation and bilateral cataracts followed by anaplastic meningioma 23 years after high-dose cranial and whole-body irradiation for acute lymphoblastic leukemia: case report and review of the literature.

Abstract
We report a case of meningioma diagnosed 23 years after high-dose cranial and whole-body irradiation for the treatment of acute lymphocytic leukemia (ALL). Radiotherapy in this case also caused early radiation injury to the lenses and the pituitary gland, with growth retardation and mineralizing angiopathy. Radiation-induced meningiomas are more commonly malignant, more commonly multiple, and more likely to recur after resection than non-radiation-induced meningiomas. Survivors of childhood ALL treated with high-dose cranial irradiation are at risk both for early radiation injury in radiosensitive organs, such as the lens and pituitary gland, and for the later development of a radiation-induced meningioma.
AuthorsAlexei I Korenkov, Hans G Imhof, Sebastian Brandner, Ethan Taub, Pia U Huguenin, Michael R Gaab, Yasuhiro Yonekawa
JournalJournal of neuro-oncology (J Neurooncol) Vol. 74 Issue 2 Pg. 195-9 (Sep 2005) ISSN: 0167-594X [Print] United States
PMID16193392 (Publication Type: Case Reports, Journal Article)
Topics
  • Adult
  • Cataract (etiology, pathology, therapy)
  • Cranial Irradiation (adverse effects)
  • Growth Disorders (etiology, pathology)
  • Humans
  • Lens, Crystalline (radiation effects)
  • Magnetic Resonance Imaging
  • Male
  • Meningeal Neoplasms (etiology, pathology, surgery)
  • Meningioma (etiology, pathology, surgery)
  • Neoplasms, Radiation-Induced (etiology, pathology, surgery)
  • Pituitary Gland (radiation effects)
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (radiotherapy)
  • Time Factors
  • Tomography, X-Ray Computed
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: